LAUSR.org creates dashboard-style pages of related content for over 1.5 million academic articles. Sign Up to like articles & get recommendations!

A multicenter randomized comparison of paclitaxel-coated balloon with plain balloon angioplasty in patients with small vessel disease

Photo by papaioannou_kostas from unsplash

AimWe investigated the efficacy and safety of using paclitaxel-coated balloon (PCB) to treat small vessel disease.Methods and resultsIn this multicenter, prospective, randomized controlled trial, one-hundred and thirty-five patients with native… Click to show full abstract

AimWe investigated the efficacy and safety of using paclitaxel-coated balloon (PCB) to treat small vessel disease.Methods and resultsIn this multicenter, prospective, randomized controlled trial, one-hundred and thirty-five patients with native coronary lesions in small vessels were randomized into a PCB group and plain balloon angioplasty (POBA) group at a ratio of 2:1. There were no differences in target vessel failure (TVF) that was defined as cardiac death or target vessel-related myocardial infarction or target lesion revascularization (TLR), between the two groups (3.4 vs. 10.3%; P = 0.20), and TLR was slightly lower in the PCB group (2.3%) than that in the POBA group (10.3%) during 24 weeks follow-up. The late lumen loss (LLL) was significantly lower in the PCB group (0.01 ± 0.31 vs. 0.32 ± 0.34 mm; P < 0.01) and late lumen enlargement (LLE) was more frequently observed in the PCB group (48 vs. 15%; P < 0.01) by angiographic follow-up after 24 weeks. There were no cases of death, myocardial infarction, thrombosis and reocclusion in either group.ConclusionsThis study was not able to demonstrate superiority of PCB compared with POBA.

Keywords: group; paclitaxel coated; small vessel; pcb; balloon; coated balloon

Journal Title: Clinical Research in Cardiology
Year Published: 2017

Link to full text (if available)


Share on Social Media:                               Sign Up to like & get
recommendations!

Related content

More Information              News              Social Media              Video              Recommended



                Click one of the above tabs to view related content.